Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Dr. James “Jim” R. Poliquin, RPVI, FACS, FSVM, is a vascular and endovascular surgeon in the Department of Vascular Surgery in the Sydell and Arnold Miller Family Heart & Vascular Institute. He is board certified in surgery and endovascular medicine. His specialty interests include minimally invasive endovascular procedures to open obstructed blood vessels with balloon angioplasty and stenting, abdominal aortic aneurysm repair (both open and endograft), aorto-femoral bypass, femoral popliteal/tibial/distal bypass, carotid endarterectomy, arterio-venous surgery, venous access catheters and venous disease treatment including deep venous thrombosis and varicose veins.
A graduate of the Medical College of Virginia, Virginia Commonwealth University, Richmond, Va., Dr. Poliquin served a surgical internship at Tripler Army Medical Center, Honolulu, Hawaii, followed by three years as a flight surgeon and general medical officer with the U.S. Army.
After his military service, Dr. Poliquin completed his general surgery residency at Eastern Virginia Medical School, Norfolk, Va., and his vascular surgery fellowship at St. Vincent Medical Center, Medical College of Ohio, Toledo, Ohio. Dr. Poliquin completed his endovascular fellowship at the Cleveland Clinic and joined the Cleveland Clinic medical staff in 2009.
He is a fellow of the American College of Surgeons and the Society for Vascular Surgery and the Society for Vascular Medicine and is a member of numerous professional organizations, including the Vascular and Endovascular Surgery Society (formerly the Peripheral Vascular Surgery Society) and the Cleveland Vascular Surgery Society.
In his leisure time Dr. Poliquin enjoys tennis, swimming, his dogs, and photography.
Endovascular and Vascular surgery
Fellow, American College of Surgeons
Member, Ohio Chapter, American College of Surgeons
Fellow, Society for Vascular Surgery
Fellow, Society for Vascular Medicine
Fellow, The Vascular and Endovascular Surgery Society (formerly the Peripheral Vascular Surgery Society)
Member, Cleveland Vascular Surgery Society
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 4/23/2015, Dr. Poliquin has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.